Postnatal changes in plasma ceruloplasmin and transferrin antioxidant activities in preterm babies

Biology of the Neonate

Volumn 78, Issue 2, 2000, Pages 73-76

  Lindeman, Jan H N ^a,b   Lentjes, Eef G W M ^a   Van Zoeren Grobben, Diny ^a   Berger, Howard M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b TNO   (Netherlands)

Author keywords

Antioxidants; Ceruloplasmin; Newborn; Non protein bound iron; Transferrin

Indexed keywords

CERULOPLASMIN; IRON; IRON BINDING PROTEIN; TRANSFERRIN;

ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; ENZYME ACTIVITY; HUMAN; NEWBORN; OXIDATIVE STRESS; PERINATAL PERIOD; PEROXIDATION; PREMATURITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; UMBILICAL CORD BLOOD;

EID: 0033822997     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000014252     Document Type: Article

References (30)

1. Phelps DL: Neonatal oxygen toxicity: Is it preventable? Pediatr Clin North Am 1982;29: 1233-1240.
2. Wispe JR, Roberts RJ: Molecular basis of pulmonary oxygen toxicity. Clin Perinatol 1987; 14:651-666.
3. Gutteridge JMC, Halliwell B: Iron toxicity and oxygen radicals. Baillières Clin Haematol 1989;2:195-256.
4. Slater TF, Cheeseman H. Davies MJ, Proud-foot K, Xin W: Free radical mechanisms in relation to tissue injury. Proc Nutr Soc 1987; 46:1-12.
5. Halliwell B, Gutteridge JMC: The antioxidants of human extracellular fluids. Arch Biochem Biophys 1990;280:1-8.
6. Lindeman JHN, Houdkamp E, Lentjes EGWM, Poorthuis BJHM, Berger HM: Limited protection against iron induced lipid peroxidation by cord blood plasma. Free Radic Res Commun 1992;16:285-294.
7. Sullivan JL, Newton RB: Serum antioxidant activity in neonates. Arch Dis Child 1988;63: 748-750.
8. Evans PJ, Evans R. Kovar IZ, Holton AF, Halliwell B: Bleomycin-detectable iron in the plasma of premature and full-term neonates. FEBS Lett 1992;303:210-212.
9. Tyrala EE: Trace elements; in Yu VYH, McMahon RA (eds): Intravenous Feeding of the Neonate, London, Arnold, 1992, pp 76-79.
10. Shaw JC: Iron absorption by the premature infant. Acta Paediatr Scand 1982;299(suppl): 83-89.
11. Halliday HL, Lappin TRJ, McClure G: Iron status of the preterm infant during the first year of life. Biol Neonate 1984;45:228-235.
12. Tanabe S. Shioiri T, Murakami K, Imanari T: A new method of ferroxidase activity and its application to human and rabbit sera. Chem Pharm Bull (Tokyo) 1984;32:4029-4035.
13. Hershko C, Pcto TE: Non-transferrin plasma iron. Br J Haematol 1987;66:149-151.
14. Halliwell B. Gutteridge JMC: Free Radicals in Biology and Medicine. Oxford, Clarendon Press, 1989.
15. Gerber CE, Bruchelt G, Stegmann H, Schweinsberg F, Speer CP: Presence of bleomycin-detectable free iron in the alveolar system of preterm infants. Biochem Biophys Res Commun 1999;257:218-222.
16. Sullivan JL: Iron, plasma antioxidants, and the 'oxygen radical disease of prematurity'. Am J Dis Child 1988;142:1341-1344.
17. Haga P, Kran S: Ceruloplasmin levels and erythrocyte Superoxide dismutase activity in small preterm babies during the early anemia of prematurity. Acta Paediatr Scand 1981;70: 861-864.
18. Gutteridge JMC: Plasma ascorbale levels and inhibition of the antioxidant activity of caeruloplasmin. Clin Sci 1991;81:413-417.
19. Powers HJ, Loban A, Silvers K. Gibson AT: Vitamin C at concentrations observed in premature babies inhibits the ferroxidase activity of caeruloplasmin. Free Radic Res 1995;22: 57-65.
20. Lovstad RA: A study on ascorbate inhibition of ceruloplasmin ferroxidase activity. Biometals 1997;10:123-126.
21. Van Zocren-Grobben D. Lindeman JHN, Houdkamp E, Brand R, Schrijver J, Berger HM: Postnatal changes in plasma chain-breaking antioxidants in healthy preterm infants fed formula and/or human milk. Am J Clin Nutr 1994;60:900-906.
22. Lentjes EGWM, Lindeman JHN, van de Bent W: Measured versus calculated latent iron binding capacity in plasma of newborns. Ann Clin Biochem 1995;32:478-481.
23. Moak SA, Greenwald RA: Enhancement of rat serum ceruloplasmin levels by exposure to hyperoxia. Proc Soc Exp Biol Med 1984;177:97-103.
24. Pracht ER, Davies WB: Role of transferrin and ceruloplasmin in antioxidant activity of lung epithelial lining fluid. J Appl Physiol 1988;64: 2092-2099.
25. Omene JA, Longe AC, Ihongbe JC, Glew RH, Holzman IR: Decreased umbilical cord serum ceruloplasmin concentrations in infants with hyaline membrane disease. J Pediatr 1981;99: 136-138.
26. McCarthy K, Bhogal M, Nardi M, Hart D: Pathogenic factors in bronchopulmonary dysplasia. Pediatr Res 1984;18:483-487.
27. Shah M, Bry K, Hallman M: Protective effect of exogenous transferrin against hyperoxia: A study on premature rabbits. Pediatr Pulmonol 1997;24:429-437.
28. Berger TM, Polidori MC, Dabbagh A: Antioxidant activity of vitamin C in iron-overloaded human plasma. J Biol Chem 1997;272:15656-15660.
29. Berger HM, Lindeman JHN, van Zoeren-Grobben D, Houdkamp E, Schrijver J, Kanhai HHH: Iron overload, free radical damage, and rhesus haemolytic disease. Lancet 1990;335: 933-936.
30. Williams ML, Shoot RJ, O'Neil PL, Oski FA: Role of dietary iron and fat on vitamin E deficiency anemia of infancy. N Engl J Med 1975; 292:887-890.